GlaxoSmithKline sets aside £2.2bn ($3.4bn) to cover costs relating to investigations into its drugs, including Avandia.
Leave a commentOther Posts
- Related Articles
- More from Author

GlaxoSmithKline sets aside £2.2bn ($3.4bn) to cover costs relating to investigations into its drugs, including Avandia.
Leave a comment